Calliditas Therapeutics AB (publ) (CALT)
USD 40.0
(-0.1%)
USD 40.0
(-0.1%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -367.8 Million SEK | 12.83% |
| 2022 | -388.81 Million SEK | 19.55% |
| 2021 | -483.93 Million SEK | -38.43% |
| 2020 | -379.39 Million SEK | -1407.56% |
| 2019 | -25.13 Million SEK | 81.13% |
| 2018 | -133.14 Million SEK | -57.37% |
| 2017 | -84.6 Million SEK | -50.0% |
| 2016 | -56.4 Million SEK | -9.99% |
| 2015 | -51.27 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -203.82 Million SEK | -754.05% |
| 2024 Q2 | -31.5 Million SEK | 84.46% |
| 2023 Q3 | -159.57 Million SEK | -112.27% |
| 2023 Q4 | 29.41 Million SEK | 118.44% |
| 2023 Q2 | -75.17 Million SEK | 58.25% |
| 2023 Q1 | -180.07 Million SEK | -654.16% |
| 2023 FY | - SEK | 12.83% |
| 2022 Q1 | -208.36 Million SEK | 6.2% |
| 2022 Q2 | -209.84 Million SEK | -0.71% |
| 2022 FY | - SEK | 19.55% |
| 2022 Q4 | 32.49 Million SEK | 189.7% |
| 2022 Q3 | -36.22 Million SEK | 82.74% |
| 2021 FY | - SEK | -38.43% |
| 2021 Q1 | -150.78 Million SEK | -10.92% |
| 2021 Q4 | -222.13 Million SEK | -2927.56% |
| 2021 Q3 | 7.85 Million SEK | 104.93% |
| 2021 Q2 | -159.39 Million SEK | -5.72% |
| 2020 FY | - SEK | -1407.56% |
| 2020 Q2 | -66.56 Million SEK | 7.97% |
| 2020 Q1 | -72.32 Million SEK | -225.79% |
| 2020 Q3 | -104.89 Million SEK | -57.58% |
| 2020 Q4 | -135.94 Million SEK | -29.6% |
| 2019 Q4 | -22.2 Million SEK | 57.83% |
| 2019 Q2 | 85.41 Million SEK | 299.93% |
| 2019 Q1 | -42.72 Million SEK | 3.54% |
| 2019 FY | - SEK | 81.13% |
| 2019 Q3 | -52.63 Million SEK | -161.63% |
| 2018 Q4 | -44.29 Million SEK | -41.69% |
| 2018 Q3 | -31.26 Million SEK | -71.81% |
| 2018 Q2 | -18.19 Million SEK | 52.4% |
| 2018 Q1 | -38.22 Million SEK | 5.78% |
| 2018 FY | - SEK | -57.37% |
| 2017 Q4 | -40.56 Million SEK | -132.32% |
| 2017 Q2 | -15.47 Million SEK | -41.77% |
| 2017 Q1 | -10.91 Million SEK | 0.0% |
| 2017 FY | - SEK | -50.0% |
| 2017 Q3 | -17.46 Million SEK | -12.85% |
| 2016 FY | - SEK | -9.99% |
| 2015 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Absci Corporation | -95.45 Million USD | -285.308% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -94.324% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -42.426% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -3620.102% |
| Apollomics, Inc. | -171.74 Million USD | -114.154% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1561.708% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1073.066% |
| Bicycle Therapeutics plc | -183.4 Million USD | -100.547% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -391.618% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -122.344% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1607.614% |
| Chimerix, Inc. | -92.97 Million USD | -295.598% |
| CRISPR Therapeutics AG | -202.7 Million USD | -81.451% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1660.272% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -433.04% |
| Fortress Biotech, Inc. | -133.64 Million USD | -175.213% |
| Fortress Biotech, Inc. | -133.64 Million USD | -175.213% |
| Gritstone bio, Inc. | -126.86 Million USD | -189.921% |
| Allakos Inc. | -189.91 Million USD | -93.667% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -658.717% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -212.625% |
| Cytokinetics, Incorporated | -456.68 Million USD | 19.462% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -288.092% |
| Innoviva, Inc. | 248.96 Million USD | 247.736% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -240060.236% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3018.123% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -192.264% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -2854429.608% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -259.653% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -315.752% |
| ImmuCell Corporation | -2.5 Million USD | -14588.167% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -182.012% |
| Incyte Corporation | 919.42 Million USD | 140.004% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -182.077% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5657.154% |
| Mustang Bio, Inc. | -48.06 Million USD | -665.252% |
| MiMedx Group, Inc. | 40.51 Million USD | 1007.775% |
| MEI Pharma, Inc. | 26.38 Million USD | 1494.249% |
| MacroGenics, Inc. | 2.01 Million USD | 18335.151% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 85827.172% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1311.587% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -3019.017% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -193.077% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 151.628% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1595.614% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2216.14% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -3359.071% |
| NextCure, Inc. | -59.03 Million USD | -522.983% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -618.099% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -3589.837% |
| Onconetix, Inc. | -36.7 Million USD | -902.004% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 16556.51% |
| Opthea Limited | -200.01 Million USD | -83.884% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -526.44% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -13266.975% |
| PDS Biotechnology Corporation | -40.08 Million USD | -817.558% |
| Precigen, Inc. | -89.22 Million USD | -312.215% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1515.864% |
| Prime Medicine, Inc. | -193.75 Million USD | -89.825% |
| PureTech Health plc | -11.62 Million USD | -3063.353% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -55.439% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 107.903% |
| Replimune Group, Inc. | -230.19 Million USD | -59.777% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -386215.226% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2065.968% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1946.368% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 14.58% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1425.4% |
| Sesen Bio, Inc. | -50.84 Million USD | -623.452% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -320.697% |
| Solid Biosciences Inc. | -93.43 Million USD | -293.65% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -59.955% |
| SciSparc Ltd. | -5.28 Million USD | -6863.328% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -441.564% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1509.207% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -222.383% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -5033.329% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -12.738% |
| UroGen Pharma Ltd. | -63.83 Million USD | -476.214% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -491.352% |
| XOMA Corporation | -39.36 Million USD | -834.411% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -33.502% |
| AbCellera Biologics Inc. | -192.15 Million USD | -91.407% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -548.065% |
| Cassava Sciences, Inc. | -95.68 Million USD | -284.381% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -727.701% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1047.878% |
| Dyadic International, Inc. | -8.22 Million USD | -4369.194% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -3546.669% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -126292.784% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1157.102% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -200.233% |
| IGM Biosciences, Inc. | -253.35 Million USD | -45.171% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -243.411% |
| Acelyrin, Inc. | -381.52 Million USD | 3.597% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -627.286% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 461.559% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1747.106% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1421.985% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -133.979% |
| Senti Biosciences, Inc. | -61.33 Million USD | -499.653% |
| Mesoblast Limited | -61.33 Million USD | -499.702% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -156.844% |
| ChromaDex Corporation | -3.89 Million USD | -9345.378% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7576.21% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -5255.315% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 148877.992% |
| Seer, Inc. | -97.88 Million USD | -275.75% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1449.623% |
| Novavax, Inc. | -487.39 Million USD | 24.536% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -16248.842% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -113.555% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -605.306% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -63.287% |
| Celcuity Inc. | -58.3 Million USD | -530.772% |
| ContextLogic Inc. | -324 Million USD | -13.519% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -131.251% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -375.548% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 125.376% |
| Amarin Corporation plc | -50.9 Million USD | -622.577% |
| AnaptysBio, Inc. | -143.16 Million USD | -156.91% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1199.152% |
| Aptorum Group Limited | -9.59 Million USD | -3731.682% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -56.469% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -109.369% |
| Ardelyx, Inc. | -55.35 Million USD | -564.456% |
| Celularity Inc. | -183.94 Million USD | -99.952% |
| Omeros Corporation | -163.61 Million USD | -124.805% |
| Humacyte, Inc. | -96.45 Million USD | -281.309% |
| Immunocore Holdings plc | -59.64 Million USD | -516.612% |
| IO Biotech, Inc. | -91.22 Million USD | -303.169% |
| GT Biopharma, Inc. | 5.97 Million USD | 6251.581% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -402.23% |
| Summit Therapeutics Inc. | 1 Million USD | 36843.556% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1090.147% |
| Pulmatrix, Inc. | -12.64 Million USD | -2808.453% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 27.357% |
| Evogene Ltd. | -23.2 Million USD | -1485.084% |
| CorMedix Inc. | -48.88 Million USD | -652.353% |
| BioLineRx Ltd. | -57.06 Million USD | -544.579% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1033.341% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1096.496% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -11.341% |
| scPharmaceuticals Inc. | -46.06 Million USD | -698.513% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -239.014% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 439.54% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3018.123% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1425.4% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -147.46% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -2593.935% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1341.291% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -227.507% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -347.269% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -541.041% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1965.186% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1097.996% |
| bluebird bio, Inc. | -167.16 Million USD | -120.029% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 218.538% |
| DBV Technologies S.A. | -85.98 Million USD | -327.767% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -57.519% |
| Galecto, Inc. | -37.51 Million USD | -880.311% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1001.668% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -676.513% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -77.947% |
| GlycoMimetics, Inc. | -39.12 Million USD | -840.144% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -61.719% |
| ADMA Biologics, Inc. | 5.12 Million USD | 7283.652% |
| Clene Inc. | -43.24 Million USD | -750.589% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -22.779% |
| Aptose Biosciences Inc. | -52.26 Million USD | -603.687% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -241.369% |
| Soligenix, Inc. | -7.85 Million USD | -4583.688% |
| Century Therapeutics, Inc. | -121.2 Million USD | -203.448% |
| Kura Oncology, Inc. | -164.95 Million USD | -122.972% |
| Surrozen, Inc. | -41.13 Million USD | -794.223% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -359.191% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -38303.26% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -8435.693% |
| Autolus Therapeutics plc | -156.77 Million USD | -134.613% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -334.463% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1745.104% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -226.837% |
| GRI Bio, Inc. | -10.89 Million USD | -3274.959% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -8044.956% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -417.857% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -254.365% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -864.521% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2299.095% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -4371.024% |
| Jaguar Health, Inc. | -33.13 Million USD | -1010.148% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2236.26% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -547.028% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1495.121% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -38.273% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -89.649% |
| Verastem, Inc. | -83.16 Million USD | -342.252% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -132.451% |
| Histogen Inc. | -10.5 Million USD | -3401.885% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2475.704% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -442.266% |
| Surrozen, Inc. | -41.13 Million USD | -794.223% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2384.148% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 11468855.847% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -4311.163% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -121.48% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -646.68% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2343.056% |
| Kronos Bio, Inc. | -121.83 Million USD | -201.899% |
| Turnstone Biologics Corp. | -56.23 Million USD | -554.058% |
| Synaptogenix, Inc. | -8.3 Million USD | -4327.357% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2297.829% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -114480.374% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -483.379% |
| Exelixis, Inc. | 196.6 Million USD | 287.08% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -160.099% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 25.728% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -465.981% |
| ESSA Pharma Inc. | -26.45 Million USD | -1290.28% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -9095.199% |
| Avid Bioservices, Inc. | -11.48 Million USD | -3103.58% |
| Insmed Incorporated | -654.73 Million USD | 43.824% |
| MediWound Ltd. | -4.89 Million USD | -7416.922% |
| OmniAb, Inc. | -49.73 Million USD | -639.585% |
| Alector, Inc. | -142.89 Million USD | -157.399% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -330.511% |
| Zai Lab Limited | -366.57 Million USD | -0.336% |
| AlloVir, Inc. | -190.14 Million USD | -93.432% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -26.551% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -235.134% |
| Aura Biosciences, Inc. | -83.69 Million USD | -339.451% |
| Immunic, Inc. | -99.11 Million USD | -271.098% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -179.337% |
| Veracyte, Inc. | -49.4 Million USD | -644.405% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -5106.775% |
| FibroGen, Inc. | -261.4 Million USD | -40.702% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3201.346% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 523.678% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -5153.332% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1865.088% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1346.79% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1022.043% |
| Fortrea Holdings Inc. | 167.3 Million USD | 319.846% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -173.908% |
| XBiotech Inc. | -35.76 Million USD | -928.359% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -465.981% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -141.694% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 69627.977% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -463.683% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -252.116% |
| Agenus Inc. | -145.92 Million USD | -152.051% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1332.701% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -800.0% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 28.783% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -556.545% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -216.159% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1559.046% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -201.224% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -6556.408% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1348.5% |
| Lantern Pharma Inc. | -15.78 Million USD | -2229.83% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| Ainos, Inc. | -8.77 Million USD | -4092.396% |
| Pluri Inc. | -20.22 Million USD | -1718.556% |
| Prothena Corporation plc | -190.1 Million USD | -93.471% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -186.902% |
| Rallybio Corporation | -72.37 Million USD | -408.205% |
| Kodiak Sciences Inc. | -259.02 Million USD | -41.996% |
| Cue Biopharma, Inc. | -46.05 Million USD | -698.669% |
| MeiraGTx Holdings plc | -57.05 Million USD | -544.68% |
| Annexon, Inc. | -141.57 Million USD | -159.794% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -472.938% |
| Moderna, Inc. | -3.28 Billion USD | 88.797% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1798.632% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1409.555% |
| Blueprint Medicines Corporation | -474.61 Million USD | 22.504% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2179.444% |
| CalciMedica, Inc. | -34.18 Million USD | -975.793% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -168.295% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -118.344% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -525.622% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -45.728% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1015.704% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -263.388% |
| Nutriband Inc. | -5.12 Million USD | -7081.16% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -749.979% |
| Vor Biopharma Inc. | -114.37 Million USD | -221.588% |
| Roivant Sciences Ltd. | -996.51 Million USD | 63.091% |
| Alkermes plc | 495.04 Million USD | 174.296% |
| ProKidney Corp. | -147.66 Million USD | -149.073% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -469.928% |
| Arcellx, Inc. | -64.14 Million USD | -473.393% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 34.956% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -229.107% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -181980.693% |
| Atai Life Sciences N.V. | -36.31 Million USD | -912.924% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -362.546% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -352.33% |
| MediciNova, Inc. | -9.87 Million USD | -3622.714% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -192.044% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -23936.254% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1279.152% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -63.475% |
| Biomea Fusion, Inc. | -124.62 Million USD | -195.14% |
| RenovoRx, Inc. | -11.39 Million USD | -3129.175% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -93.236% |
| Geron Corporation | -174.78 Million USD | -110.435% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1124.989% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -243.362% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -57.534% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1509.289% |
| Royalty Pharma plc | 1.88 Billion USD | 119.489% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -76.968% |
| Imunon, Inc. | -19.87 Million USD | -1750.276% |
| BioAtla, Inc. | -122.24 Million USD | -200.884% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -22.481% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -787.406% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -121.461% |
| Structure Therapeutics Inc. | -102.45 Million USD | -258.976% |
| 89bio, Inc. | -134.46 Million USD | -173.535% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -270.567% |
| aTyr Pharma, Inc. | -52.17 Million USD | -604.901% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -338.827% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -56.802% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -4473.356% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2089.043% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 195007.952% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 181.382% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -125.006% |
| Liquidia Corporation | -70.05 Million USD | -425.05% |
| Entera Bio Ltd. | -8.8 Million USD | -4077.681% |
| GH Research PLC | -41.15 Million USD | -793.745% |
| Vericel Corporation | 2.86 Million USD | 12942.284% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -418.135% |
| Xencor, Inc. | -125.87 Million USD | -192.199% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -25682.783% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2299.095% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1724.635% |
| Vaxcyte, Inc. | -464.88 Million USD | 20.883% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -74.717% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -3261.387% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5657.154% |
| Portage Biotech Inc. | -18.19 Million USD | -1921.007% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -23936.254% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -251.682% |
| OncoCyte Corporation | -23.12 Million USD | -1490.637% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3154.79% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3110.336% |
| Purple Biotech Ltd. | -22.22 Million USD | -1554.907% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1178.159% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1169.906% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -118.327% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -5637.956% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1146.621% |
| United Therapeutics Corporation | 1.38 Billion USD | 126.522% |
| HilleVax, Inc. | -132.46 Million USD | -177.658% |
| Silo Pharma, Inc. | -3.62 Million USD | -10042.893% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -5913.247% |
| Pharming Group N.V. | 9.87 Million USD | 3823.833% |
| Tharimmune, Inc. | -9.3 Million USD | -3853.77% |
| Genprex, Inc. | -31.06 Million USD | -1084.148% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -337.939% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -96.134% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -368.581% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -48041.754% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 243833.102% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2335769.66% |
| Savara Inc. | -59.13 Million USD | -521.993% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1724.51% |
| Curis, Inc. | -45.13 Million USD | -714.823% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2321.167% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1275.787% |
| BeiGene, Ltd. | -1.12 Billion USD | 67.295% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -307.132% |
| Erasca, Inc. | -121.31 Million USD | -203.193% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -8075.66% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -8075.66% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -763.205% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -6412.093% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -514.521% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -164.542% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -78.667% |
| Adicet Bio, Inc. | -136.53 Million USD | -169.384% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -299.443% |
| Aditxt, Inc. | -25.45 Million USD | -1344.746% |
| Adagene Inc. | -14.95 Million USD | -2360.092% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4931.437% |
| Quantum-Si incorporated | -91.8 Million USD | -300.639% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 390.857% |
| Compugen Ltd. | -12.51 Million USD | -2838.663% |
| Generation Bio Co. | -133.3 Million USD | -175.921% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -342.976% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -327.564% |
| Invivyd, Inc. | -196.61 Million USD | -87.068% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 1.697% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -3865.617% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1454.508% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3476.111% |
| 2seventy bio, Inc. | -206.41 Million USD | -78.184% |
| Instil Bio, Inc. | -146.12 Million USD | -151.71% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1498.52% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -8512.962% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1279.152% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -901.387% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 7590.507% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -132.193% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 46.252% |
| Evaxion Biotech A/S | -21.4 Million USD | -1618.465% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -453.795% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -68.974% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -362.111% |
| Cingulate Inc. | -22.95 Million USD | -1502.486% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -4829.674% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -886.517% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -530.102% |
| Clearmind Medicine Inc. | -8.71 Million USD | -4122.446% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -394.745% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -14965.163% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -264.786% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 3.202% |
| ImmunityBio, Inc. | -436.18 Million USD | 15.677% |
| Korro Bio, Inc. | -80.9 Million USD | -354.617% |
| Kineta, Inc. | -15.71 Million USD | -2240.607% |
| BioVie Inc. | -31.95 Million USD | -1051.176% |
| Codexis, Inc. | -49.28 Million USD | -646.308% |
| Celularity Inc. | -183.94 Million USD | -99.952% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2255.748% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -66.044% |
| Virax Biolabs Group Limited | -6.6 Million USD | -5465.063% |
| Cibus, Inc. | -314.58 Million USD | -16.917% |
| IN8bio, Inc. | -28.5 Million USD | -1190.356% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -226.649% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1215.697% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -59.907% |
| Eyenovia, Inc. | -24.1 Million USD | -1425.771% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 921.282% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -113419.444% |
| Elevation Oncology, Inc. | -41.46 Million USD | -786.978% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -398.351% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -717.086% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -197.874% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1090.995% |
| Moolec Science SA | -52.07 Million USD | -606.287% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -612.714% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -810.021% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -207.546% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -658.779% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3844.584% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1673.335% |
| Humacyte, Inc. | -96.45 Million USD | -281.309% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -366.311% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 9177.073% |
| Genelux Corporation | -24.16 Million USD | -1422.048% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -988.175% |
| Notable Labs, Ltd. | -14.4 Million USD | -2454.188% |
| Immunovant, Inc. | -269.97 Million USD | -36.234% |
| Quantum-Si incorporated | -91.8 Million USD | -300.639% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1804.925% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -260.549% |
| Acasti Pharma Inc. | -11.3 Million USD | -3154.606% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1552.806% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -893.257% |
| PepGen Inc. | -83.58 Million USD | -340.05% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1506.337% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -7607.949% |
| Immuneering Corporation | -58.06 Million USD | -533.479% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 11468855.847% |
| Belite Bio, Inc | -31.52 Million USD | -1066.555% |
| XOMA Corporation | -39.36 Million USD | -834.411% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -445.322% |
| Bionomics Limited | -9.83 Million USD | -3638.977% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -962.83% |
| uniQure N.V. | -253.1 Million USD | -45.319% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4931.437% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -184.009% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1032.503% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -4468.713% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1203.388% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -113419.444% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3201.346% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2213.081% |
| Altimmune, Inc. | -87.93 Million USD | -318.267% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -200.876% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -962.83% |
| Peak Bio, Inc. | -1356.23 USD | -27119415.126% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -656.827% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1535.407% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -51.795% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1188.593% |
| Zura Bio Limited | -60.56 Million USD | -507.306% |
| PolyPid Ltd. | -20.26 Million USD | -1715.146% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1188.593% |
| argenx SE | -216.02 Million USD | -70.261% |
| Immunome, Inc. | -28.27 Million USD | -1200.99% |
| Verona Pharma plc | -52.46 Million USD | -601.01% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -288.092% |
| Shattuck Labs, Inc. | -87.61 Million USD | -319.795% |
| CervoMed Inc. | -2.17 Million USD | -16834.822% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -2797.684% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -663.489% |
| Moolec Science SA | -52.07 Million USD | -606.287% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2045.877% |
| Design Therapeutics, Inc. | -66.32 Million USD | -454.547% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -354.151% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -874.313% |
| Achilles Therapeutics plc | -70.44 Million USD | -422.136% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -14965.163% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -563.521% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -627.602% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -463.45% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -579.733% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -710.567% |
| Beam Therapeutics Inc. | -156.47 Million USD | -135.058% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -169.472% |
| AEON Biopharma, Inc. | -48.36 Million USD | -660.536% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -462.691% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -348.913% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -2878.156% |
| NeurAxis, Inc. | -6.66 Million USD | -5418.843% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 13.951% |
| Lumos Pharma, Inc. | -36.57 Million USD | -905.751% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 6409.614% |
| Palisade Bio, Inc. | -12.28 Million USD | -2894.895% |
| Nutriband Inc. | -5.12 Million USD | -7081.16% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -249.633% |
| Neurogene Inc. | -52.28 Million USD | -603.445% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -4280.693% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -295.411% |
| Athira Pharma, Inc. | -116.7 Million USD | -215.162% |
| HCW Biologics Inc. | -23.57 Million USD | -1460.07% |
| XOMA Corporation | -39.36 Million USD | -834.411% |
| Nektar Therapeutics | -243.1 Million USD | -51.293% |
| Arvinas, Inc. | -394.8 Million USD | 6.838% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 195007.952% |
| Merus N.V. | -149.2 Million USD | -146.505% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -293.414% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1076.593% |
| Rezolute, Inc. | -68.42 Million USD | -437.543% |
| Clene Inc. | -43.24 Million USD | -750.589% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2284.895% |
| BeyondSpring Inc. | -21.54 Million USD | -1607.535% |
| Synlogic, Inc. | -55.16 Million USD | -566.781% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -2943.971% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -3356.145% |
| Peak Bio, Inc. | -1356.23 USD | -27119415.126% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1032.922% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2154.306% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -210.584% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -7.751% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -7884.553% |
| MannKind Corporation | 15.12 Million USD | 2531.112% |
| Ikena Oncology, Inc. | -74.39 Million USD | -394.379% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -2820.694% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1909.431% |
| Gossamer Bio, Inc. | -172.15 Million USD | -113.65% |
| CohBar, Inc. | -12.06 Million USD | -2948.32% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1341.856% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1124.989% |
| Legend Biotech Corporation | -477.87 Million USD | 23.033% |
| Mural Oncology plc | -192.72 Million USD | -90.848% |
| Disc Medicine, Inc. | -91.02 Million USD | -304.068% |
| Champions Oncology, Inc. | -5.05 Million USD | -7177.463% |
| REGENXBIO Inc. | -239.46 Million USD | -53.594% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3331.578% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -559.665% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -848.722% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -226.049% |
| Vaxart, Inc. | -74.72 Million USD | -392.222% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -944.649% |
| Cellectis S.A. | -98.09 Million USD | -274.946% |
| Longeveron Inc. | -20.06 Million USD | -1733.514% |
| Repare Therapeutics Inc. | -114.27 Million USD | -221.863% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 16.255% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -391.636% |
| Revolution Medicines, Inc. | -430.58 Million USD | 14.58% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -5748.354% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1094.592% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -393.1% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 7601.591% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -3254.337% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 107.987% |
| Denali Therapeutics Inc. | -179.97 Million USD | -104.366% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -386215.226% |
| Veru Inc. | -89.97 Million USD | -308.781% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1268.417% |
| Cingulate Inc. | -22.95 Million USD | -1502.486% |
| Passage Bio, Inc. | -98.34 Million USD | -274.008% |
| Context Therapeutics Inc. | -25.06 Million USD | -1367.656% |
| Exicure, Inc. | -15.53 Million USD | -2266.967% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -78.49% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -894.707% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -6068.504% |
| Nuvalent, Inc. | -149.49 Million USD | -146.035% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -4422.679% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -328.206% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1118.779% |
| OmniAb, Inc. | -49.73 Million USD | -639.585% |
| Anew Medical, Inc. | -1.3 Million USD | -28174.269% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -2874.79% |
| Lipocine Inc. | -16.32 Million USD | -2153.327% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -451.677% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -395.004% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -864.521% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -842.746% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1558.04% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 32.522% |
| Ocugen, Inc. | -64.82 Million USD | -467.361% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -297.324% |
| Q32 Bio Inc. | -86.5 Million USD | -325.196% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2072.878% |
| Alumis Inc. Common Stock | -156.89 Million USD | -134.434% |
| Equillium, Inc. | -12.13 Million USD | -2930.178% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -529.024% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4553.761% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1850.074% |
| Dominari Holdings Inc. | -22.44 Million USD | -1539.051% |
| Edesa Biotech, Inc. | -8.19 Million USD | -4390.801% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1347.36% |
| Bio-Techne Corporation | 326.66 Million USD | 212.594% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 4.433% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 269.973% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -180.534% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -882.616% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -143.415% |
| Nkarta, Inc. | -120.48 Million USD | -205.279% |
| BioCardia, Inc. | -11.56 Million USD | -3081.687% |
| Iterum Therapeutics plc | -34.58 Million USD | -963.629% |